Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study

International Journal of Cancer

Volumn 140, Issue 8, 2017, Pages 1727-1735

  Huang, Jiaqi ^a   Zagai, Ulrika ^a   Hallmans, Göran ^b   Nyrén, Olof ^a   Engstrand, Lars ^a   Stolzenberg Solomon, Rachael ^c   Duell, Eric J ^d   Overvad, Kim ^e   Katzke, Verena A ^f   Kaaks, Rudolf ^f   Jenab, Mazda ^g   Park, Jin Young ^g   Murillo, Raul ^g   Trichopoulou, Antonia ^h,i   Lagiou, Pagona ^h,i,j   Bamia, Christina ^h,i   Bradbury, Kathryn E ^k   Riboli, Elio ^l   Aune, Dagfinn ^l   Tsilidis, Konstantinos K ^l,u   Capellá, Gabriel ^d   Agudo, Antonio ^d   Krogh, Vittorio ^m   Palli, Domenico ⁿ   Panico, Salvatore ^o   Weiderpass, Elisabete ^a,p,q,r   Tjønneland, Anne ^s   Olsen, Anja ^s   Martínez, Begoña ^t   Redondo Sanchez, Daniel ^t,w,ai   Chirlaque, Maria Dolores ^v,w,x   HM Peeters, Petra ^y   Regnér, Sara ^z   Lindkvist, Björn ^aa   Naccarati, Alessio ^ab   Ardanaz, Eva ^w,ac   Larrañaga, Nerea ^w,ad   Boutron Ruault, Marie Christine ^ae,af,ag   Rebours, Vinciane ^ah   Barré, Amélie ^af   Bueno de Mesquita, H Bas ^l,y,aj,ak   Ye, Weimin ^a,b   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e AARHUS UNIVERSITY   (Denmark)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^h HELLENIC HEALTH FOUNDATION   (Greece)

ⁱ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^j HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^o UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^p UNIVERSITY OF TROMSØ   (Norway)

^q CANCER REGISTRY OF NORWAY   (Norway)

^r FOLKHÄLSAN RESEARCH CENTER   (Finland)

^s DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^t ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^u UNIVERSITY OF IOANNINA   (Greece)

^v DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^w CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^x UNIVERSITY OF MURCIA   (Spain)

^y UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^z LUND UNIVERSITY   (Sweden)

^aa SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^ab Human Genetics Foundation   (Italy)

^ac IdiSNA Navarra Institute for Health Research   (Spain)

^ad Public Health Division of Gipuzkoa   (Spain)

^ae INSERM   (France)

^af UNIVERSITÉ PARIS SACLAY   (France)

^ag INSTITUT GUSTAVE ROUSSY   (France)

^ah BEAUJON HOSPITAL   (France)

^ai UNIVERSITY OF GRANADA   (Spain)

^aj NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ak UNIVERSITY OF MALAYA   (Malaysia)

more..

Author keywords

chronic corpus atrophic gastritis; EPIC cohort; H. pylori infection; nested case control study; pancreatic cancer risk

Indexed keywords

CAGA PROTEIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CASE CONTROL STUDY; CHRONIC CORPUS ATROPHIC GASTRITIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PROSPECTIVE STUDY; GASTRITIS, ATROPHIC; GENETICS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NUTRITIONAL STATUS; PANCREATIC NEOPLASMS; PATHOGENICITY;

ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PANCREATIC NEOPLASMS;

EID: 85013381974     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30590     Document Type: Article

References (40)

1. Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 2008;10:58–62.
2. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108.
3. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29.
4. Lepage C, Capocaccia R, Hackl M, et al. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: results of EUROCARE-5. Eur J Cancer, in press.
5. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014;74:2913–21.
6. Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol 2015;44:186–98.
7. Wolpin BM, Kraft P, Gross M, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 2010;70:1015–23.
8. Case J, Raeburn C, Walther WW. Blood-groups in relation to malignant diseases. Lancet 1956;271:970–2.
9. Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011;105 Suppl 2:S77–81.
10. Humans IWGotEoCRt. Biological Agents. Volume 100 B. A review of human carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans/World Health Organization, International Agency for Research on Cancer 2012;100:1–441.
11. Adami HO HD, Trichopoulos D. Stomach cancer. In: Nyrén O, Adami HO, eds. Textbook of Cancer Epidemiology, 2nd edn. New York: Oxford University Press, 2008. 239–374.
12. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297–301.
13. Huang JQ, Zheng GF, Sumanac K, et al. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003;125:1636–44.
14. Xiao M, Wang Y, Gao Y. Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis. PLoS One 2013;8:e75559.
15. Wang Y, Zhang FC, Wang YJ. Helicobacter pylori and pancreatic cancer risk: a meta- analysis based on 2,049 cases and 2,861 controls. Asian Pac J Cancer Prev 2014;15:4449–54.
16. Schulte A, Pandeya N, Fawcett J, et al. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis. Cancer Causes Control 2015;26:1027–35.
17. Kuipers EJ. Proton pump inhibitors and gastric neoplasia. Gut 2006;55:1217–21.
18. El-Zimaity H. Gastritis and gastric atrophy. Curr Opin Gastroenterol 2008;24:682–6.
19. de Vries AC, Kuipers EJ. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies. Helicobacter 2007;12 Suppl 2:22–31.
20. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113–24.
21. Storskrubb T, Aro P, Ronkainen J, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008;43:1448–55.
22. Raderer M, Wrba F, Kornek G, et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 1998;55:16–9.
23. Stolzenberg-Solomon RZ, Blaser MJ, et al. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001;93:937–41.
24. Risch HA, Yu H, Lu L, et al. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010;102:502–5.
25. Risch HA, Lu L, Kidd MS, et al. Helicobacter pylori seropositivities and risk of pancreatic carcinoma. Cancer Epidemiol Biomarkers Prev 2014;23:172–8.
26. Lindkvist B, Johansen D, Borgstrom A, et al. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer 2008;8:321.
27. de Martel C, Llosa AE, Friedman GD, et al. Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2008;17:1188–94.
28. Yu G, Murphy G, Michel A, et al. Seropositivity to Helicobacter pylori and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2013;22:2416–9.
29. Shimoyama T, Takahashi R, Abe D, et al. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol 2010;25 Suppl 1:S86–9.
30. Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 2003;95:948–60.
31. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735–40.
32. Houben GM, Stockbrugger RW. Bacteria in the aetio-pathogenesis of gastric cancer: a review. Scand J Gastroenterol Suppl 1995;212:13–8.
33. Anderson KE PJ, Mack TM. Pancreatic cancer. In: Schotenfeld D, Fraumeni JFJ, editors. Cancer Epidemiology and Prevention. New York: Oxford University Press, 1996. 725–71.
34. Luo J, Nordenvall C, Nyren O, et al. The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease. Int J Cancer 2007;120:368–72.
35. Borch K, Kullman E, Hallhagen S, et al. Increased incidence of pancreatic neoplasia in pernicious anemia. World J Surg 1988;12:866–70.
36. Hsing AW, Hansson LE, McLaughlin JK, et al. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993;71:745–50.
37. Laiyemo AO, Kamangar F, Marcus PM, et al. Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer—a prospective cohort study. Cancer Epidemiol 2009;33:368–73.
38. Weck MN, Gao L, Brenner H. Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease. Epidemiology 2009;20:569–74.
39. Ye W, Held M, Enroth H, et al. Histology and culture results among subjects with antibodies to CagA but no evidence of Helicobacter pylori infection with IgG ELISA. Scand J Gastroenterol 2005;40:312–8.
40. Duell EJ, Bonet C, Munoz X, et al. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population. Int J Cancer 2015;136:880–93.